MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/biomedicines10081851

Медицинская библиотека · Biomedicines · 2022

Exploiting Bacteria for Improving Hypoxemia of COVID-19 Patients.

Trinchieri Vito, Marazzato Massimiliano, Ceccarelli Giancarlo, Lombardi Francesca, Piccirilli Alessandra, Santinelli Letizia, Maddaloni Luca, Vassalini Paolo, Mastroianni Claudio Maria, d'Ettorre Gabriella

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Although useful in the time-race against COVID-19, CPAP cannot provide oxygen over the physiological limits imposed by severe pulmonary impairments. In previous studies, we reported that the administration of the SLAB51 probiotics reduced risk of developing respiratory failure in severe COVID-19 patients through the activation of oxygen sparing mechanisms providing additional oxygen to organs critical for survival.

METHODS

This "real life" study is a retrospective analysis of SARS-CoV-2 infected patients with hypoxaemic acute respiratory failure secondary to COVID-19 pneumonia undergoing CPAP treatment. A group of patients managed with ad interim routinely used therapy (RUT) were compared to a second group treated with RUT associated with SLAB51 oral bacteriotherapy (OB).

RESULTS

At baseline, patients receiving SLAB51 showed significantly lower blood oxygenation than controls. An opposite condition was observed after 3 days of treatment, despite the significantly reduced amount of oxygen received by patients taking SLAB51. At 7 days, a lower prevalence of COVID-19 patients needing CPAP in the group taking probiotics was observed. The administration of SLAB51 is a complementary approach for ameliorating oxygenation conditions at the systemic level.

CONCLUSION

This study proves that probiotic administration results in an additional boost in alleviating hypoxic conditions, permitting to limit on the use of CPAP and its contraindications.

Для цитирования: Trinchieri Vito, Marazzato Massimiliano, Ceccarelli Giancarlo, Lombardi Francesca, Piccirilli Alessandra, Santinelli Letizia, Maddaloni Luca, Vassalini Paolo, Mastroianni Claudio Maria, d'Ettorre Gabriella. Exploiting Bacteria for Improving Hypoxemia of COVID-19 Patients.. Biomedicines. 2022. DOI: 10.3390/biomedicines10081851.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.